Logo image of HCAP

Harvest Capital Cred (HCAP) Stock Fundamental Analysis

NASDAQ:HCAP - Nasdaq -

9.66  +0.16 (+1.68%)

Fundamental Rating

2

Taking everything into account, HCAP scores 2 out of 10 in our fundamental rating. HCAP was compared to 225 industry peers in the Capital Markets industry. HCAP has a bad profitability rating. Also its financial health evaluation is rather negative. HCAP is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year HCAP was profitable.

1.2 Ratios

Industry RankSector Rank
ROA 5.42%
ROE 8.69%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 7.61%
PM (TTM) 55.42%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

3

2. Health

2.1 Basic Checks

There is no outstanding debt for HCAP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

A Debt/Equity ratio of 0.58 indicates that HCAP is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

HCAP has a Current Ratio of 18.21. This indicates that HCAP is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 18.21 indicates that HCAP has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 18.21
Quick Ratio 18.21

More info and screens

2

3. Growth

3.1 Past

The earnings per share for HCAP have decreased strongly by -80.88% in the last year.
Measured over the past years, HCAP shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -28.89% on average per year.
Looking at the last year, HCAP shows a very negative growth in Revenue. The Revenue has decreased by -19.05% in the last year.
HCAP shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -10.69% yearly.
EPS 1Y (TTM)-80.88%
EPS 3Y-41.24%
EPS 5Y-28.89%
EPS Q2Q%-88.24%
Revenue 1Y (TTM)-19.05%
Revenue growth 3Y-14.85%
Revenue growth 5Y-10.69%
Sales Q2Q%-33.17%

3.2 Future

The Earnings Per Share is expected to grow by 15.60% on average over the next years. This is quite good.
HCAP is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -10.12% yearly.
EPS Next Y27.5%
EPS Next 2Y26.6%
EPS Next 3Y18.77%
EPS Next 5Y15.6%
Revenue Next Year-21.63%
Revenue Next 2Y-10.2%
Revenue Next 3Y-10.37%
Revenue Next 5Y-10.12%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
HCAP Yearly Revenue VS EstimatesHCAP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
HCAP Yearly EPS VS EstimatesHCAP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.5 1 1.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 74.31 indicates a quite expensive valuation of HCAP.
The average S&P500 Price/Earnings ratio is at 29.62. HCAP is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 21.52, the valuation of HCAP can be described as rather expensive.
When comparing the Price/Forward Earnings ratio of HCAP to the average of the S&P500 Index (22.70), we can say HCAP is valued inline with the index average.
Industry RankSector Rank
PE 74.31
Fwd PE 21.52
HCAP Price Earnings VS Forward Price EarningsHCAP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 18.94
HCAP Per share dataHCAP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
HCAP's earnings are expected to grow with 18.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.7
PEG (5Y)N/A
EPS Next 2Y26.6%
EPS Next 3Y18.77%

More info and screens

3

5. Dividend

5.1 Amount

HCAP has a Yearly Dividend Yield of 3.93%. Purely for dividend investing, there may be better candidates out there.
HCAP's Dividend Yield is rather good when compared to the S&P500 average which is at 2.27.
Industry RankSector Rank
Dividend Yield 3.93%

5.2 History

The dividend of HCAP decreases each year by -19.03%.
HCAP has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)-19.03%
Div Incr YearsN/A
Div Non Decr YearsN/A
HCAP Yearly Dividends per shareHCAP Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 0.2 0.4 0.6 0.8 1

5.3 Sustainability

DPN/A
EPS Next 2Y26.6%
EPS Next 3Y18.77%

More info and screens

Harvest Capital Cred

NASDAQ:HCAP (6/8/2021, 8:00:01 PM)

9.66

+0.16 (+1.68%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)N/A N/A
Earnings (Next)03-11 2022-03-11/amc
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners16.85%
Ins Owner Change0%
Market Cap57.65M
Analysts0
Price Target8.16 (-15.53%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.93%
Yearly Dividend0.38
Dividend Growth(5Y)-19.03%
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 74.31
Fwd PE 21.52
P/S 5.51
P/FCF N/A
P/OCF N/A
P/B 0.86
P/tB N/A
EV/EBITDA 18.94
EPS(TTM)0.13
EY1.35%
EPS(NY)0.45
Fwd EY4.65%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.75
BVpS11.17
TBVpSN/A
PEG (NY)2.7
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.42%
ROE 8.69%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 7.61%
PM (TTM) 55.42%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 18.21
Quick Ratio 18.21
Altman-Z N/A
F-Score8
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-80.88%
EPS 3Y-41.24%
EPS 5Y-28.89%
EPS Q2Q%-88.24%
EPS Next Y27.5%
EPS Next 2Y26.6%
EPS Next 3Y18.77%
EPS Next 5Y15.6%
Revenue 1Y (TTM)-19.05%
Revenue growth 3Y-14.85%
Revenue growth 5Y-10.69%
Sales Q2Q%-33.17%
Revenue Next Year-21.63%
Revenue Next 2Y-10.2%
Revenue Next 3Y-10.37%
Revenue Next 5Y-10.12%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A